|
| Home : Quark Venture announces US$4.5 million in funding to support critical work in cancer immunotherapy of two world-leading scientists at Harvard Medical School (HMS) |
|
Apr 07
2017 |
Quark Venture announces US$4.5 million in funding to support critical work in cancer immunotherapy of two world-leading scientists at Harvard Medical School (HMS) |
|
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 6, 2017) - Today, Quark Venture Inc. announced a signing of a unique research sponsorship agreement with Harvard University's Office of Technology Development (OTD). The US$4.5 million supports the joint research of principal investigators Arlene Sharpe, MD, PhD, and Dennis Kasper, MD, trailblazers in their fields of cancer immunology and microbiome science, respectively. |
|
|
|
| Source:http://www.marketwired.com/mw/release.do?id=2208281&sourceType=3 |
| |
|
Related News
|
» ThreeD Capital Inc. Announces Completion of Private Placement, Appointment of VP Business Development and General Counsel, and Resignation of a Director
» Para Arranges $4,000,000 Non-Brokered Private Placement
|
|
|
